March 18th, 2015
•Here, we describe a robust protocol for human cardiomyocyte derivation that combines small molecule-modulated cardiac differentiation and glucose deprivation-mediated cardiomyocyte purification, enabling production of purified cardiomyocytes for the purposes of cardiovascular disease modeling and drug screening.
Vídeos Relacionados
Three-dimensional Quantification of Dendritic Spines from Pyramidal Neurons Derived from Human Induced Pluripotent Stem Cells
Feeder-free Derivation of Melanocytes from Human Pluripotent Stem Cells
Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2
Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol
Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells
Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix
Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells
Derivation and Differentiation of Canine Ovarian Mesenchymal Stem Cells
Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados